Ketogenic diet may boost targeted cancer therapy

An extreme low carbohydrate, high-fat regimen called the ketogenic diet may improve the effectiveness of an emerging class of cancer drugs, finds a study in mice by investigators at Weill Cornell Medicine, Columbia University Irving Medical Center and NewYork-Presbyterian. In the work, scientists provide a possible explanation for why the drugs, which target the insulin-activated ?

https://reliawire.com/keto-pi3k-inhibitors/

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →